Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 83
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT04925661 | HEC53856 Phase Ib Study in Patients With Non-dialysis Renal Anemia | ||
| NCT04827069 | A Clinical Trial to Evaluate Clifutinib in Patients with Relapsed or Refractory Acute Myeloid Leukemia(AML) | ||
| NCT03092102 | The Safety, Tolerability and Pharmacokinetic Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT05057949 | A Study to Evaluate Drug-Drug Interaction of Larotinib With Itraconazole and Rifampin in Healthy Adult Participants | ||
| NCT04147208 | Evaluate the Safety, Tolerability, and Antiviral Activity of GLS4 With Ritonavir in Patients With Chronic HBV Infection | ||
| NCT05139719 | A Study to Explore the Therapeutic Effect of HEC585 on Delaying Forced Vital Capacity (FVC) Decline and Tolerance in Progressive Fibrosing Interstitial Lung Disease (PF-ILD) Patients | ||
| NCT03943251 | The Study of a Selective Serotonin Partial Agonist and Reuptake Inhibitors, HEC113995PA•H2O,in Healthy Subjects | ||
| NCT07211165 | Clinical Study on the Mass Balance of Clifutinib | ||
| NCT04512170 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC585 in Healthy Male and Female Subjects | ||
| NCT05391360 | Evaluation Freethiadine Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT04984512 | The Efficacy And Safety Of Mitizodone Phosphate Tablets In The Treatment of Patient With Major Depressive Disorder | ||
| NCT04324372 | Clinical Study of HEC68498 in Patients With Advanced Refractory Solid Tumors | ||
| NCT05060822 | Phase ll Study of HEC585 in Patients With IPF | ||
| NCT03462173 | The Safety, Tolerability and Pharmacokinetic Study of Yimitasvir in Healthy Adults Subjects | ||
| NCT04667429 | the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets | ||
| NCT04551261 | GLS4/RTV and TAF Drug-drug Interaction | ||
| NCT05383131 | To Evaluate Drug-drug Interactions Between HEC585 and Pirfenidone or Nintedanib in Healthy Volunteers | ||
| NCT04131192 | Gemcitabine and Z650 in Treating Patients With Metastatic or Recurrent Pancreatic Cancer | ||
| NCT05446233 | ADME Study of [14C] Antaitavir Hasophate in Healthy Male Subjects | ||
| NCT04623814 | the Safety, Tolerability, and Pharmacokinetics Study of HEC113995 | ||
| NCT05492630 | Single and Multiple Dose Safety, Tolerability, PK and Food Effect Study of HEC73077 in Healthy Subjects | ||
| NCT04536532 | Evaluation HEC121120 Tolerance in Healthy Subjects and Patients With Chronic Hepatitis B, Pharmacokinetics Characteristics and Antiviral Activity of Ⅰ Phase of Study | ||
| NCT03638076 | The Safety, Antiviral Activity, and Pharmacokinetics of Morphothiadine Mesilate Capsules | ||
| NCT05427682 | A Clinical Trial to Evaluate the Pharmacokinetics and Safety of Pyroglutamate Rongliflozin Capsules in Subjects With Mild and Moderate Liver Damage | ||
| NCT05059743 | ADME Study of [14C]- Larotinib in Healthy Male Subjects | ||
| NCT04982913 | Single Dose and Multiple Dose Safety, Tolerability, PK，and Food Effect Study，and Interaction With Oseltamivir Study of HEC116094 in Healthy Adult Subjects | ||
| NCT04601610 | KN046 Combined With Ningatinib in the Treatment of Advanced Hepatocellular Carcinoma | ||
| NCT05397379 | A Safety, Tolerability, Efficacy, and Pharmacokinetics Study of HEC96719 in Subjects With Non-Cirrhotic Non-Alcoholic Steatohepatitis | ||
| NCT04202952 | The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC110114 Tablets in HCV-infected Subjects | ||
| NCT03487107 | Phase 3 Study of Yimitasvir Phosphate Capsules | ||
| NCT05451602 | HEC169096 in Participants With Advanced Solid Tumors | ||
| NCT04992858 | Ningetinib in Advanced NSCLC Skipping Mutations With MET Exon 14 Skipping Mutations | ||
| NCT03663686 | The Safety, Tolerability and Pharmacokinetic Study of Litapiprant Tablets in Healthy Male and Female Subjects | ||
| NCT05294536 | A Pharmacokinetic Study Comparing the Liraglutide Injection (RD12014) and Victoza® in Healthy Chinese Subjects | ||
| NCT04422496 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC96719 Tablets in Healthy Subjects | ||
| NCT04596007 | The Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC83518 Tablets in Chinses Healthy Subjects | ||
| NCT07771140 | A Phase I Clinical Trial to Evaluate HECN30227 Injection in Healthy Subjects and Subjects With Chronic Hepatitis B | ||
| NCT05468346 | Study on the Body Mass Balance and Biotransformation of [14C]-HEC585 | ||
| NCT07341672 | A Single-center, Randomized, Open-label, Parallel-design Clinical Study to Evaluate the Pharmacokinetic Effects of Itraconazole, Fluconazole or Efavirenz on a Single Dose of Clifutinib in Healthy Participants | ||
| NCT05127772 | A Clinical Trial of HEC93077 in Chinese Healthy Subjects and HUA Patients With Single or Multiple Dosing | ||
| NCT07102251 | A Study to Evaluate the Safety, Tolerability, PK/PD of HEC-007 Injection in Healthy and Overweight/Obese Subjects | ||
| NCT04415853 | Study of Larotinib in Unresectable Advanced or Recurrent Esophageal Cancer | ||
| NCT03655873 | The Study of a Selective 5-ht6 Receptor Antagonist, HEC30654AcOH,in Healthy Subjects | ||
| NCT04552808 | To Evaluate the Pharmacokinetics and Safety of Yimitasvir Phosphate Capsules in Subjects With Moderate and Severe Liver Function Impairment and in Healthy Subjects | ||
| NCT03662568 | A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects | ||
| NCT05998304 | ADME Study of [14C] Yiqibuvir in Healthy Male Subjects | ||
| NCT05576298 | A Clinical Study Comparing the Pharmacokinetics and Pharmacodynamic Characteristics of Insulin Degludec Injection (RD15003) and Insulin Degludec Injection (Tresiba®) in Healthy Subjects | ||
| NCT07824934 | HEC-921 Injection as Monotherapy and in Combination With Antineoplastic Therapies in Patients With Advanced Malignant Solid Tumors | ||
| NCT05802862 | A Study of Insulin Degludec/Insulin Aspart Biosimilar (22011) Compared With Insulin Degludec/Insulin Aspart(Ryzodeg) in Participants With Type 2 Diabetes in China | ||
| NCT05497674 | Effects of Rifampicin and Probenecid On The Pharmacokinetic Profile Of Rongliflozin In Healthy Subjects |
